Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sci-B-Vac Reference Standard Qualification Study
NCT04179786Phase 4Completed
- Sponsor
- VBI Vaccines Inc.
- Start
- Nov 2015
- Primary completion
- Feb 2017
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by VBI Vaccines Inc.. Started Nov 2015; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04179786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04179786.